Amador Bioscience

Kempische Steenweg 309, Corda Campus, Gebouw 2, bus 1.05

3500 Hasselt

BE

Amador Bioscience

Foundation date

11/01/2022

Sector

#Biotechnology / R&D Services

Subsector

Amador Bioscience provides global translational research and clinical development solutions. With established sites in the United States, Europe, and China, Amador confidently meets international clinical trial quality and compliance standards. We enhance the success rate of new drugs in any regulatory setting and take innovative drug development projects from pre-clinical research and development to market approval.

Upcoming events

Latest news

  • SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance

    14 hours ago

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

    Monday June 5th 2023

Jobs by Amador Bioscience